{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:58:27Z","timestamp":1791417507988,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["490191\/2012-6"],"award-info":[{"award-number":["490191\/2012-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["PPM-00015-13"],"award-info":[{"award-number":["PPM-00015-13"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Education, Science, Research and Sport of the Slovak Republic to T. D., DB Biotech, Slovakia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.nbd.2014.08.021","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T08:33:38Z","timestamp":1408869218000},"page":"163-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease"],"prefix":"10.1016","volume":"73","author":[{"given":"J.G.","family":"Doria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.G.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guatimosim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dobransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.08.021_bb0005","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1242\/dev.00378","article-title":"BDNF gene replacement reveals multiple mechanisms for establishing neurotrophin specificity during sensory nervous system development","volume":"130","author":"Agerman","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.nbd.2014.08.021_bb0010","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.08.021_bb0015","doi-asserted-by":"crossref","first-page":"34840","DOI":"10.1074\/jbc.M504508200","article-title":"Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin","volume":"280","author":"Anborgh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.08.021_bb0020","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.08.021_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2174\/156802606777323700","article-title":"Trophic effect of glutamate","volume":"6","author":"Balazs","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.nbd.2014.08.021_bb0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1523\/JNEUROSCI.21-03-00782.2001","article-title":"Effects of staurosporine on exocytosis and endocytosis at frog motor nerve terminals","volume":"21","author":"Becherer","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.021_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exnr.1999.7092","article-title":"Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease","volume":"158","author":"Calabresi","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0040","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.021_bb0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11064-011-0691-z","article-title":"Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK\/ERK pathway","volume":"37","author":"Chen","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2014.08.021_bb0050","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.021_bb0055","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2014.08.021_bb0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.08.021_bb0065","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bph.12164","article-title":"Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease","volume":"169","author":"Doria","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/381706a0","article-title":"Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus","volume":"381","author":"Figurov","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.08.021_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.08.021_bb0085","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.021_bb0080","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2174\/138920112800784817","article-title":"Metabotropic glutamate receptors as targets for novel antipsychotic treatments","volume":"13","author":"Gray","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.08.021_bb0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuron.2010.12.014","article-title":"RIM determines Ca(2)+ channel density and vesicle docking at the presynaptic active zone","volume":"69","author":"Han","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.021_bb0100","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.nbd.2014.08.021_bb0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/excr.1999.4690","article-title":"The regulation and activities of the multifunctional serine\/threonine kinase Akt\/PKB","volume":"253","author":"Kandel","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2014.08.021_bb0110","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1126\/science.7886457","article-title":"Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus","volume":"267","author":"Kang","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.08.021_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2014.08.021_bb0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jgg.2012.05.002","article-title":"Influence of species differences on the neuropathology of transgenic Huntington's disease animal models","volume":"39","author":"Li","year":"2012","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.nbd.2014.08.021_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.021_bb0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","article-title":"Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load","volume":"585","author":"Milnerwood","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/npp.2010.212","article-title":"Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5","volume":"36","author":"Reichel","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.08.021_bb0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","article-title":"Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease","volume":"30","author":"Ribeiro","year":"2010","journal-title":"J. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2014.08.021_bb0145","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1590\/1516-4446-2013-1157","article-title":"Animal models of neurodegenerative diseases","volume":"35","author":"Ribeiro","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.nbd.2014.08.021_bb0150","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","article-title":"Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease","volume":"23","author":"Ribeiro","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.021_bb0160","doi-asserted-by":"crossref","first-page":"e78342","DOI":"10.1371\/journal.pone.0078342","article-title":"Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction","volume":"8","author":"Rodrigues","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.021_bb0165","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/mol.110.067207","article-title":"Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity","volume":"78","author":"Rodriguez","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2009.12.039","article-title":"Metabotropic glutamate receptor subtype 5 antagonism in learning and memory","volume":"639","author":"Simonyi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2011.02.003","article-title":"Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator","volume":"659","author":"Spear","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0180","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.1152864","article-title":"Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines","volume":"319","author":"Tanaka","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.08.021_bb0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.021_bb0185","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.021_bb0195","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2009.07.022","article-title":"Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus","volume":"57","author":"Uslaner","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.08.021_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.021_bb0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mcn.2008.09.007","article-title":"Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments","volume":"40","author":"Warby","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.021_bb0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1172\/JCI17742","article-title":"Huntingtin in health and disease","volume":"111","author":"Young","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.08.021_bb0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:08:45Z","timestamp":1760850525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":45,"alternative-id":["S0969996114002526"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.021","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}